Latest Breaking News On - Leerink smith - Page 1 : comparemela.com

Immunovant Stock Dives On Surprise Shift To Earlier-Stage Drug

Immunovant Stock Dives On Surprise Shift To Earlier-Stage Drug
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

William-blair
Leerink-smith
Matt-phipps
Pete-salzmann
Thomas-smith
Chief-executive-pete-salzmann
Business-daily

Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal

Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

United-states
America
Leerink-smith
Geoff-meacham
Thomas-smith
Vertex-pharmaceuticals
Vertex-pharmaceuticals-adds-to-kidney-diseases-pipeline
Alpine-immune-sciences
Novartis
Otsuka-pharmaceutical
Vera-therapeutics
America-securities

Viking Stock Surges After Weight-Loss Drug Tops Expectations | Investor's Business Daily

Viking Stock Surges After Weight-Loss Drug Tops Expectations | Investor's Business Daily
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Lilly-zepbound
Eli-lilly
Novo-wegovy
Leerink-smith
Tema-etfs
Thomas-smith
Novo-nordisk
Viking-therapeutics
Leerink-partners
Taking-on-novo
David-song

Viking Stock Catapults As Weight-Loss Drug Beats Out Eli Lilly's Zepbound

Viking Stock Catapults As Weight-Loss Drug Beats Out Eli Lilly's Zepbound
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

William-blair
Eli-lilly-zepbound
David-risinger
Thomas-smith
Andy-hsieh
Leerink-smith
Novo-wegovy
Eli-lilly
Viking-therapeutics
Leerink-partners
Big-pharma
Relative-strength-rating

CBAY Stock Claws 1,417% Higher On Its Journey To Approval In PBC Treatment

CBAY Stock Claws 1,417% Higher On Its Journey To Approval In PBC Treatment
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Thomas-smith
Sujal-shah
Leerink-smith
Intercept-pharmaceuticals
Drug-administration
Cymabay-therapeutics
Cymabay-chief-executive-sujal-shah
Leerink-partners
Already-leads-the
Relative-strength-rating